Literature DB >> 23538893

Hepatic regeneration and the epithelial to mesenchymal transition.

Zeng-Fu Xue1, Xiu-Min Wu, Ming Liu.   

Abstract

Liver injuries are repaired by fibrosis and regeneration. The core stage is the repair response and fibrosis formation as a scar. The cause of overly-responsive scar formation and diminished regeneration, especially in liver fibrosis and cirrhosis, is still unknown. The epithelial to mesenchymal transition (EMT), a previously discovered mechanism, plays an important role in liver fibrosis and tumor metastasis. Recently, EMT has been found to be associated with liver and bile duct cell fibrosis. Analyzing the established models and chronic disease processes, we propose that EMT liver cells may also lose their regenerative capability due to phenotype changes and that the remaining liver cells may quickly lose their regenerative capability in liver fibrosis or cirrhosis. Recognizing these phenotype changes or transition cells may play an important role in targeting therapy to reverse fibrosis not only by disrupting the transition that is necessary to produce the extracellular matrix but also by restoring the regenerative capacity of EMT-like cells.

Entities:  

Keywords:  Epithelial to mesenchymal transition; Epithelial to mesenchymal transition -like; Fibrosis; Hepatocyte; Hepatocyte stellate cells; Liver; Regeneration; Transforming growth factor-β

Mesh:

Year:  2013        PMID: 23538893      PMCID: PMC3602497          DOI: 10.3748/wjg.v19.i9.1380

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  62 in total

Review 1.  Liver regeneration.

Authors:  Nelson Fausto; Jean S Campbell; Kimberly J Riehle
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

2.  Evidence for epithelial-mesenchymal transitions in adult liver cells.

Authors:  Jason K Sicklick; Steve S Choi; Marcia Bustamante; Shannon J McCall; Elizabeth Hernández Pérez; Jiawen Huang; Yin-Xiong Li; Marcos Rojkind; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05-18       Impact factor: 4.052

Review 3.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

4.  Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells.

Authors:  Liu Yang; Ying Wang; Hua Mao; Susanne Fleig; Alessia Omenetti; Kevin D Brown; Jason K Sicklick; Yin-Xiong Li; Anna Mae Diehl
Journal:  J Hepatol       Date:  2007-10-18       Impact factor: 25.083

5.  Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

Authors:  Michael Zeisberg; Changqing Yang; Margot Martino; Michael B Duncan; Florian Rieder; Harikrishna Tanjore; Raghu Kalluri
Journal:  J Biol Chem       Date:  2007-06-11       Impact factor: 5.157

6.  Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro.

Authors:  Aki Kaimori; James Potter; Jun-Ya Kaimori; Connie Wang; Esteban Mezey; Ayman Koteish
Journal:  J Biol Chem       Date:  2007-05-19       Impact factor: 5.157

Review 7.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 8.  Stem cells, cell transplantation and liver repopulation.

Authors:  Michael Oertel; David A Shafritz
Journal:  Biochim Biophys Acta       Date:  2007-12-23

9.  Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease.

Authors:  Karolina A Rygiel; Helen Robertson; Helen L Marshall; Marcin Pekalski; Liena Zhao; Trevor A Booth; David E J Jones; Alastair D Burt; John A Kirby
Journal:  Lab Invest       Date:  2007-12-03       Impact factor: 5.662

Review 10.  Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

Authors:  John P Iredale
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

View more
  14 in total

Review 1.  Epithelial-mesenchymal transition: An emerging target in tissue fibrosis.

Authors:  Meirong Li; Fuxin Luan; Yali Zhao; Haojie Hao; Yong Zhou; Weidong Han; Xiaobing Fu
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-11

Review 2.  The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.

Authors:  Margherita Sisto; Sabrina Lisi; Domenico Ribatti
Journal:  Histochem Cell Biol       Date:  2018-05-23       Impact factor: 4.304

Review 3.  Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?

Authors:  Kyung-Hyun Kim; Kwan-Kyu Park
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  Phycocyanobilin accelerates liver regeneration and reduces mortality rate in carbon tetrachloride-induced liver injury mice.

Authors:  Jie Liu; Qing-Yu Zhang; Li-Ming Yu; Bin Liu; Ming-Yi Li; Run-Zhi Zhu
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

5.  Epithelial-mesenchymal transition in liver fibrosis.

Authors:  Ya-Lei Zhao; Rong-Tao Zhu; Yu-Ling Sun
Journal:  Biomed Rep       Date:  2016-01-25

6.  Dual β-Catenin and γ-Catenin Loss in Hepatocytes Impacts Their Polarity through Altered Transforming Growth Factor-β and Hepatocyte Nuclear Factor 4α Signaling.

Authors:  Tirthadipa Pradhan-Sundd; Silvia Liu; Sucha Singh; Minakshi Poddar; Sungjin Ko; Aaron Bell; Jonathan Franks; Ian Huck; Donna Stolz; Udayan Apte; Sarangarajan Ranganathan; Kari Nejak-Bowen; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2021-03-01       Impact factor: 4.307

7.  Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation.

Authors:  Lucas T Woods; Jean M Camden; Farid G El-Sayed; Mahmoud G Khalafalla; Michael J Petris; Laurie Erb; Gary A Weisman
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

8.  Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease.

Authors:  Alfonso Pastor-Clerigues; Ezequiel Marti-Bonmati; Javier Milara; Patricia Almudever; Julio Cortijo
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

Review 9.  Role of NADPH oxidases in the redox biology of liver fibrosis.

Authors:  Eva Crosas-Molist; Isabel Fabregat
Journal:  Redox Biol       Date:  2015-07-14       Impact factor: 11.799

10.  Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease.

Authors:  Daisuke Yoshihara; Masanori Kugita; Mai Sasaki; Shigeo Horie; Koichi Nakanishi; Takaaki Abe; Harold M Aukema; Tamio Yamaguchi; Shizuko Nagao
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.